HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Amagai Selected Research

Desmogleins

2/2022Analysis of clinical characteristics, prognosis and antibody pathogenicity of pemphigus patients positive for anti-desmoglein IgG autoantibodies in remission: a retrospective cohort study.
1/2013Alopecia as a rare but distinct manifestation of pemphigus vulgaris.
6/2010Immune response towards the amino-terminus of desmoglein 1 prevails across different activity stages in nonendemic pemphigus foliaceus.
11/2008Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature.
9/2008Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission.
4/2008Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
10/2006Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"?
10/2002Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris.
8/2002Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.
11/2001Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Amagai Research Topics

Disease

41Pemphigus (Pemphigus Vulgaris)
02/2022 - 01/2000
8Blister (Bulla)
01/2020 - 01/2000
7Acantholysis
01/2013 - 01/2000
6Bullous Pemphigoid (Pemphigoid)
01/2020 - 01/2000
6Skin Diseases (Skin Disease)
06/2010 - 06/2000
4Infections
06/2020 - 03/2000
4Autoimmune Diseases (Autoimmune Disease)
10/2006 - 01/2000
3Alopecia (Baldness)
10/2018 - 09/2000
3Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
07/2004 - 11/2000
2Inflammation (Inflammations)
10/2021 - 03/2013
2Erythema
01/2020 - 01/2005
2Neoplasm Metastasis (Metastasis)
01/2019 - 12/2017
2Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary)
09/2014 - 05/2014
2Benign Familial Pemphigus (Hailey Hailey Disease)
06/2001 - 04/2000
1Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
10/2022
1Ulcerative Colitis
10/2022
1Urticaria (Hives)
01/2020
1Epidermal Nevus
01/2020
1Lymphatic Metastasis
01/2019
1Extramammary Paget Disease (Paget Disease, Extramammary)
01/2019
1Leukopenia
10/2018
1Mycosis Fungoides
06/2018
1Melanoma (Melanoma, Malignant)
12/2017
1Cicatrix (Scar)
01/2013
1Ulcer
12/2009
1Tuberculosis (Tuberculoses)
01/2009
1Hypersensitivity (Allergy)
01/2006
1Systemic Scleroderma (Systemic Sclerosis)
01/2005
1Lung Diseases (Lung Disease)
05/2004
1Liver Diseases (Liver Disease)
06/2001
1Dermatitis
04/2001
1Eosinophilic pustular folliculitis
03/2001
1Allergic Contact Dermatitis
03/2001
1Staphylococcal Scalded Skin Syndrome (Ritter's Disease)
11/2000
1Impetigo (Impetigo Contagiosa)
11/2000
1Thymoma (Thymic Carcinoma)
09/2000
1Darier Disease (Darier's Disease)
04/2000
1Plasma Cell Leukemia
03/2000
1Psoriasis (Pustulosis Palmaris et Plantaris)
03/2000
1Linear IgA Bullous Dermatosis
03/2000

Drug/Important Bio-Agent (IBA)

33AutoantibodiesIBA
02/2022 - 01/2000
19Immunoglobulin G (IgG)IBA
02/2022 - 01/2000
16DesmogleinsIBA
02/2022 - 01/2000
14EnzymesIBA
06/2020 - 01/2000
11Desmoglein 1IBA
06/2010 - 01/2000
11ImmunosorbentsIBA
09/2008 - 05/2000
10Immunoglobulin A (IgA)IBA
05/2006 - 01/2000
9AntibodiesIBA
06/2010 - 01/2000
8Desmoglein 3IBA
11/2004 - 01/2000
7AntigensIBA
11/2002 - 01/2000
5Proteins (Proteins, Gene)FDA Link
10/2006 - 04/2000
4Pharmaceutical PreparationsIBA
01/2006 - 11/2000
4DesmocollinsIBA
07/2004 - 11/2000
4AutoantigensIBA
05/2004 - 03/2000
3Cadherins (E-Cadherin)IBA
11/2000 - 04/2000
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 01/2001
2Azathioprine (Imuran)FDA LinkGeneric
10/2018 - 06/2001
2Nonsense Codon (Nonsense Mutation)IBA
09/2014 - 05/2014
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2004 - 03/2000
2Desmoplakins (Desmoplakin)IBA
11/2001 - 05/2000
2EpitopesIBA
11/2001 - 11/2000
1tofacitinibIBA
10/2022
1SteroidsIBA
02/2022
1cholesterol 25-hydroxylaseIBA
10/2021
1CholesterolIBA
10/2021
1Immunoglobulin E (IgE)IBA
01/2020
1ErbB Receptors (EGF Receptor)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2019
1Carcinoembryonic AntigenIBA
01/2019
1CytokinesIBA
01/2019
1Laminin (Merosin)IBA
01/2019
1Keratin-19 (Keratin 19)IBA
01/2019
1antigen CYFRA21.1IBA
01/2019
1Monoacylglycerol LipasesIBA
12/2017
1LipidsIBA
12/2017
1Collagen Type IV (Type IV Collagen)IBA
03/2013
116S Ribosomal RNAIBA
12/2009
1Cell Adhesion MoleculesIBA
04/2008
1Penicillamine (Cuprimine)FDA Link
01/2005
1Antigen-Antibody Complex (Immune Complex)IBA
10/2003
1AcitretinFDA Link
11/2002
1Vinblastine (Vinblastine Sulfate)FDA Link
06/2001
1Adenosine Triphosphatases (ATPase)IBA
06/2001
1NucleosidesIBA
06/2001
1fludarabineIBA
06/2001
1Indomethacin (Indometacin)FDA LinkGeneric
03/2001
1Betamethasone Valerate (Betamethasone 17 Valerate)FDA LinkGeneric
03/2001
1Recombinant ProteinsIBA
01/2001
1Isotretinoin (Accutane)FDA LinkGeneric
11/2000
1Collagen Type XVIIIBA
08/2000
1Keratins (Keratin)IBA
05/2000
1Desmosomal CadherinsIBA
04/2000
1Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2000
1Prednisolone (Predate)FDA LinkGeneric
03/2000
1Interleukin-8 (Interleukin 8)IBA
01/2000

Therapy/Procedure

5Therapeutics
08/2020 - 01/2009
1Plasmapheresis
04/2008
1Thymectomy
09/2000
1Drug Therapy (Chemotherapy)
03/2000